Share Price and Basic Stock Data
Last Updated: January 8, 2026, 7:03 pm
| PEG Ratio | 0.32 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Ugro Capital Ltd operates within the Finance & Investments sector, focusing on providing financial solutions to small and medium enterprises (SMEs). The company reported a current market capitalization of ₹2,569 Cr, with a share price of ₹167. Revenue growth has been robust, climbing from ₹149 Cr in September 2022 to ₹245 Cr by September 2023, reflecting a year-on-year increase of 64.4%. This upward trajectory continued into December 2023, where revenue reached ₹268 Cr. Notably, for the fiscal year ending March 2025, Ugro is on track to report revenues of ₹1,396 Cr, up from ₹684 Cr in March 2023, marking a significant increase that underscores its expanding market presence. The quarterly revenue figures indicate a consistent growth pattern, with the most recent quarterly figure for June 2025 projected at ₹414 Cr, suggesting sustained demand for its financial products.
Profitability and Efficiency Metrics
Ugro Capital’s profitability indicators showcase a mixed yet improving performance. The net profit for the last fiscal year stood at ₹144 Cr, with a net profit margin of 10.31% for March 2025, demonstrating a solid profitability framework compared to typical sector norms. The return on equity (ROE) was reported at 7.03% for the same period, indicating effective utilization of shareholder funds, although it remains below the industry average. The interest coverage ratio (ICR) stood at 1.40x, reflecting the company’s ability to meet interest obligations comfortably, albeit at a level that could be a concern if it does not improve. Furthermore, gross and net non-performing asset (NPA) ratios were recorded at 2.30% and 1.60% respectively for March 2025, which are relatively high compared to the sector average, posing a potential risk to profitability if not managed effectively.
Balance Sheet Strength and Financial Ratios
Ugro Capital’s balance sheet reflects a growing asset base, with total assets increasing from ₹4,306 Cr in March 2023 to ₹9,168 Cr by March 2025. The company’s reserves have also strengthened, rising to ₹1,954 Cr in March 2025, up from ₹915 Cr in March 2023. However, the total debt to equity ratio stood at 3.37x, indicating a highly leveraged position, which may raise concerns among investors regarding financial stability. The price-to-book value (P/BV) ratio is currently at 0.73x, suggesting that the stock may be undervalued compared to its book value, offering potential upside. Additionally, the company reported an enterprise value of ₹7,869 Cr, which, when juxtaposed with its revenue from operations, reflects a valuation that may warrant further investigation for value-oriented investors seeking opportunities in the financial sector.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Ugro Capital illustrates a diversified ownership structure. Promoters hold a mere 1.83% of the company, which may raise questions about management’s commitment to shareholders. Foreign institutional investors (FIIs) have increased their stake to 24.21%, indicating growing confidence in Ugro’s business model. Domestic institutional investors (DIIs) hold 1.50%, while the public constitutes 70.72% of the shareholding. The number of shareholders has expanded significantly, from 12,010 in March 2023 to 40,064 by November 2025, suggesting increasing retail investor interest. This broadening of the shareholder base could enhance liquidity and market perception, although the low promoter holding might be viewed negatively by certain investors, potentially impacting long-term investor sentiment.
Outlook, Risks, and Final Insight
Looking ahead, Ugro Capital’s growth trajectory appears promising, driven by a solid revenue increase and strengthening balance sheet. However, risks remain, particularly with high leverage and increasing NPA ratios that could pressure profitability. The company must focus on maintaining asset quality and managing its debt levels to sustain investor confidence and profitability. Additionally, the low promoter shareholding could deter some investors from fully embracing the stock. Ugro Capital’s ability to navigate these challenges while capitalizing on its growth potential will be critical. Should the company enhance its operational efficiency and improve asset quality, it stands to gain significantly in a competitive financial landscape, positioning itself as a favored choice among investors seeking exposure to the financial sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 11.2 Cr. | 38.2 | 61.0/36.4 | 44.8 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,373 Cr. | 300 | 484/280 | 15.3 | 111 | 0.33 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 29.5 Cr. | 0.42 | 1.62/0.38 | 4.09 | 0.03 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 5.02 Cr. | 10.1 | 11.6/8.25 | 9.25 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 20.8 Cr. | 40.5 | 69.9/38.6 | 19.9 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 7,217.96 Cr | 1,348.71 | 75.99 | 3,844.57 | 0.36% | 21.71% | 14.20% | 7.28 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 149 | 182 | 209 | 213 | 245 | 268 | 322 | 291 | 330 | 371 | 403 | 414 | 455 |
| Interest | 69 | 82 | 90 | 93 | 105 | 117 | 128 | 136 | 143 | 167 | 181 | 205 | 219 |
| Expenses | 64 | 81 | 87 | 82 | 99 | 107 | 136 | 113 | 139 | 152 | 161 | 156 | 167 |
| Financing Profit | 16 | 19 | 32 | 38 | 41 | 44 | 58 | 43 | 48 | 52 | 61 | 53 | 69 |
| Financing Margin % | 11% | 11% | 15% | 18% | 17% | 16% | 18% | 15% | 15% | 14% | 15% | 13% | 15% |
| Other Income | 6 | 8 | 8 | 5 | 9 | 12 | 8 | 10 | 13 | 14 | 9 | 8 | 6 |
| Depreciation | 5 | 5 | 6 | 8 | 9 | 9 | 10 | 10 | 11 | 12 | 13 | 13 | 14 |
| Profit before tax | 18 | 22 | 34 | 36 | 41 | 46 | 56 | 43 | 50 | 53 | 57 | 48 | 61 |
| Tax % | 70% | 41% | 58% | 29% | 29% | 30% | 42% | 29% | 29% | 29% | 29% | 29% | 29% |
| Net Profit | 5 | 13 | 14 | 25 | 29 | 33 | 33 | 30 | 36 | 38 | 41 | 34 | 43 |
| EPS in Rs | 0.59 | 1.47 | 1.57 | 2.16 | 2.47 | 2.78 | 2.78 | 2.58 | 3.02 | 3.18 | 3.44 | 2.92 | 3.71 |
| Gross NPA % | 1.70% | 1.70% | 2.46% | 1.80% | 1.90% | 2.00% | 2.00% | 2.00% | 2.10% | 2.10% | 2.30% | 2.50% | 2.40% |
| Net NPA % | 1.20% | 1.10% | 1.31% | 1.00% | 1.10% | 1.10% | 1.10% | 1.20% | 1.30% | 1.50% | 1.60% | 1.70% | 1.50% |
Last Updated: December 28, 2025, 5:36 pm
Below is a detailed analysis of the quarterly data for Ugro Capital Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Interest, as of Sep 2025, the value is 219.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 205.00 Cr. (Jun 2025) to 219.00 Cr., marking an increase of 14.00 Cr..
- For Expenses, as of Sep 2025, the value is 167.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 156.00 Cr. (Jun 2025) to 167.00 Cr., marking an increase of 11.00 Cr..
- For Other Income, as of Sep 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Jun 2025) to 6.00 Cr., marking a decrease of 2.00 Cr..
- For Depreciation, as of Sep 2025, the value is 14.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.00 Cr. (Jun 2025) to 14.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 61.00 Cr.. The value appears strong and on an upward trend. It has increased from 48.00 Cr. (Jun 2025) to 61.00 Cr., marking an increase of 13.00 Cr..
- For Tax %, as of Sep 2025, the value is 29.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 29.00%.
- For Net Profit, as of Sep 2025, the value is 43.00 Cr.. The value appears strong and on an upward trend. It has increased from 34.00 Cr. (Jun 2025) to 43.00 Cr., marking an increase of 9.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 3.71. The value appears strong and on an upward trend. It has increased from 2.92 (Jun 2025) to 3.71, marking an increase of 0.79.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:28 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6 | 2 | 4 | 2 | 4 | 44 | 105 | 153 | 312 | 684 | 1,082 | 1,396 | 1,644 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 14 | 45 | 137 | 293 | 443 | 628 | 772 |
| Expenses | 1 | 1 | 0 | 0 | 0 | 36 | 81 | 85 | 142 | 289 | 425 | 565 | 636 |
| Financing Profit | 5 | 2 | 3 | 2 | 3 | 7 | 11 | 24 | 33 | 101 | 214 | 204 | 235 |
| Financing Margin % | 86% | 76% | 92% | 86% | 91% | 16% | 10% | 16% | 10% | 15% | 20% | 15% | 14% |
| Other Income | 0 | 0 | 0 | 0 | 0 | -4 | 0 | 0 | 0 | 0 | 0 | 46 | 37 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 2 | 7 | 12 | 12 | 18 | 35 | 46 | 53 |
| Profit before tax | 5 | 2 | 3 | 2 | 3 | 2 | 3 | 12 | 20 | 84 | 179 | 203 | 219 |
| Tax % | 30% | 7% | 14% | 2% | 8% | -155% | -488% | -137% | 28% | 53% | 33% | 29% | |
| Net Profit | 4 | 2 | 3 | 2 | 3 | 4 | 20 | 29 | 15 | 40 | 119 | 144 | 156 |
| EPS in Rs | 6.41 | 2.83 | 5.07 | 3.34 | 5.05 | 1.34 | 2.19 | 3.22 | 1.63 | 4.46 | 10.17 | 12.22 | 13.25 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 50.00% | -33.33% | 50.00% | 33.33% | 400.00% | 45.00% | -48.28% | 166.67% | 197.50% | 21.01% |
| Change in YoY Net Profit Growth (%) | 0.00% | 100.00% | -83.33% | 83.33% | -16.67% | 366.67% | -355.00% | -93.28% | 214.94% | 30.83% | -176.49% |
Ugro Capital Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 89% |
| 5 Years: | 68% |
| 3 Years: | 65% |
| TTM: | 35% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 56% |
| 5 Years: | 49% |
| 3 Years: | 115% |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 14% |
| 3 Years: | -2% |
| 1 Year: | -23% |
| Return on Equity | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 6% |
| 3 Years: | 8% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 4, 2025, 2:09 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 23 | 71 | 71 | 71 | 69 | 92 | 92 | 114 |
| Reserves | 23 | 25 | 27 | 29 | 32 | 796 | 851 | 882 | 896 | 915 | 1,347 | 1,954 | 2,349 |
| Borrowing | 0 | 0 | 0 | 0 | 0 | 24 | 255 | 766 | 1,802 | 3,149 | 4,653 | 6,904 | 8,088 |
| Other Liabilities | 1 | 0 | 0 | 0 | 0 | 26 | 36 | 37 | 86 | 173 | 188 | 218 | 228 |
| Total Liabilities | 28 | 30 | 32 | 34 | 37 | 868 | 1,212 | 1,755 | 2,855 | 4,306 | 6,280 | 9,168 | 10,779 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 20 | 38 | 36 | 56 | 85 | 130 | 168 | 190 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 11 | 1 | 4 | 6 | 14 | 0 | 0 | 0 |
| Investments | 26 | 15 | 25 | 26 | 36 | 107 | 73 | 55 | 69 | 60 | 59 | 103 | 492 |
| Other Assets | 3 | 14 | 8 | 8 | 1 | 731 | 1,101 | 1,659 | 2,724 | 4,146 | 6,091 | 8,897 | 10,098 |
| Total Assets | 28 | 30 | 32 | 34 | 37 | 868 | 1,212 | 1,755 | 2,855 | 4,306 | 6,280 | 9,168 | 10,779 |
Below is a detailed analysis of the balance sheet data for Ugro Capital Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 114.00 Cr.. The value appears strong and on an upward trend. It has increased from 92.00 Cr. (Mar 2025) to 114.00 Cr., marking an increase of 22.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,349.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,954.00 Cr. (Mar 2025) to 2,349.00 Cr., marking an increase of 395.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 228.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 218.00 Cr. (Mar 2025) to 228.00 Cr., marking an increase of 10.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 10,779.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,168.00 Cr. (Mar 2025) to 10,779.00 Cr., marking an increase of 1,611.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 190.00 Cr.. The value appears strong and on an upward trend. It has increased from 168.00 Cr. (Mar 2025) to 190.00 Cr., marking an increase of 22.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 492.00 Cr.. The value appears strong and on an upward trend. It has increased from 103.00 Cr. (Mar 2025) to 492.00 Cr., marking an increase of 389.00 Cr..
- For Other Assets, as of Sep 2025, the value is 10,098.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,897.00 Cr. (Mar 2025) to 10,098.00 Cr., marking an increase of 1,201.00 Cr..
- For Total Assets, as of Sep 2025, the value is 10,779.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,168.00 Cr. (Mar 2025) to 10,779.00 Cr., marking an increase of 1,611.00 Cr..
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 12.00 | -174.00 | -681.00 | 141.00 | 286.00 | 421.00 | 559.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE % | 15% | 6% | 10% | 6% | 8% | 1% | 2% | 3% | 2% | 4% | 10% | 8% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 15.68 | 13.39 | 5.69 | 2.06 | 4.07 |
| Diluted EPS (Rs.) | 14.71 | 13.20 | 5.66 | 2.05 | 4.07 |
| Cash EPS (Rs.) | 20.70 | 16.89 | 8.28 | 3.81 | 5.74 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 222.57 | 157.04 | 141.95 | 136.99 | 135.04 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 222.57 | 157.04 | 141.95 | 136.99 | 135.04 |
| Revenue From Operations / Share (Rs.) | 151.82 | 114.42 | 94.70 | 43.55 | 21.24 |
| PBDIT / Share (Rs.) | 95.41 | 71.73 | 56.94 | 24.08 | 9.70 |
| PBIT / Share (Rs.) | 90.37 | 67.88 | 54.40 | 22.33 | 8.04 |
| PBT / Share (Rs.) | 22.09 | 19.52 | 12.09 | 2.86 | 1.72 |
| Net Profit / Share (Rs.) | 15.65 | 13.03 | 5.74 | 2.06 | 4.07 |
| PBDIT Margin (%) | 62.84 | 62.69 | 60.13 | 55.29 | 45.67 |
| PBIT Margin (%) | 59.52 | 59.32 | 57.44 | 51.27 | 37.84 |
| PBT Margin (%) | 14.55 | 17.05 | 12.76 | 6.56 | 8.09 |
| Net Profit Margin (%) | 10.31 | 11.38 | 6.05 | 4.73 | 19.17 |
| Return on Networth / Equity (%) | 7.03 | 8.29 | 4.04 | 1.50 | 3.01 |
| Return on Capital Employeed (%) | 38.12 | 20.96 | 17.06 | 9.25 | 4.50 |
| Return On Assets (%) | 1.56 | 1.90 | 0.92 | 0.50 | 1.64 |
| Long Term Debt / Equity (X) | 0.00 | 0.99 | 1.16 | 0.72 | 0.31 |
| Total Debt / Equity (X) | 3.37 | 3.24 | 3.20 | 1.86 | 0.80 |
| Asset Turnover Ratio (%) | 0.18 | 0.19 | 0.18 | 0.13 | 0.10 |
| Current Ratio (X) | 1.27 | 1.83 | 1.97 | 2.36 | 3.36 |
| Quick Ratio (X) | 1.27 | 1.83 | 1.97 | 2.36 | 3.36 |
| Interest Coverage Ratio (X) | 1.40 | 1.48 | 1.35 | 1.24 | 1.54 |
| Interest Coverage Ratio (Post Tax) (X) | 1.23 | 1.27 | 1.14 | 1.11 | 1.64 |
| Enterprise Value (Cr.) | 7869.00 | 6209.26 | 3942.28 | 2792.18 | 1301.28 |
| EV / Net Operating Revenue (X) | 5.64 | 5.92 | 6.01 | 9.09 | 8.69 |
| EV / EBITDA (X) | 8.97 | 9.45 | 9.99 | 16.43 | 19.02 |
| MarketCap / Net Operating Revenue (X) | 1.08 | 1.92 | 1.53 | 3.84 | 5.68 |
| Price / BV (X) | 0.73 | 1.40 | 1.02 | 1.22 | 0.89 |
| Price / Net Operating Revenue (X) | 1.08 | 1.92 | 1.53 | 3.84 | 5.68 |
| EarningsYield | 0.09 | 0.05 | 0.03 | 0.01 | 0.03 |
After reviewing the key financial ratios for Ugro Capital Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 15.68. This value is within the healthy range. It has increased from 13.39 (Mar 24) to 15.68, marking an increase of 2.29.
- For Diluted EPS (Rs.), as of Mar 25, the value is 14.71. This value is within the healthy range. It has increased from 13.20 (Mar 24) to 14.71, marking an increase of 1.51.
- For Cash EPS (Rs.), as of Mar 25, the value is 20.70. This value is within the healthy range. It has increased from 16.89 (Mar 24) to 20.70, marking an increase of 3.81.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 222.57. It has increased from 157.04 (Mar 24) to 222.57, marking an increase of 65.53.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 222.57. It has increased from 157.04 (Mar 24) to 222.57, marking an increase of 65.53.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 151.82. It has increased from 114.42 (Mar 24) to 151.82, marking an increase of 37.40.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 95.41. This value is within the healthy range. It has increased from 71.73 (Mar 24) to 95.41, marking an increase of 23.68.
- For PBIT / Share (Rs.), as of Mar 25, the value is 90.37. This value is within the healthy range. It has increased from 67.88 (Mar 24) to 90.37, marking an increase of 22.49.
- For PBT / Share (Rs.), as of Mar 25, the value is 22.09. This value is within the healthy range. It has increased from 19.52 (Mar 24) to 22.09, marking an increase of 2.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 15.65. This value is within the healthy range. It has increased from 13.03 (Mar 24) to 15.65, marking an increase of 2.62.
- For PBDIT Margin (%), as of Mar 25, the value is 62.84. This value is within the healthy range. It has increased from 62.69 (Mar 24) to 62.84, marking an increase of 0.15.
- For PBIT Margin (%), as of Mar 25, the value is 59.52. This value exceeds the healthy maximum of 20. It has increased from 59.32 (Mar 24) to 59.52, marking an increase of 0.20.
- For PBT Margin (%), as of Mar 25, the value is 14.55. This value is within the healthy range. It has decreased from 17.05 (Mar 24) to 14.55, marking a decrease of 2.50.
- For Net Profit Margin (%), as of Mar 25, the value is 10.31. This value exceeds the healthy maximum of 10. It has decreased from 11.38 (Mar 24) to 10.31, marking a decrease of 1.07.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.03. This value is below the healthy minimum of 15. It has decreased from 8.29 (Mar 24) to 7.03, marking a decrease of 1.26.
- For Return on Capital Employeed (%), as of Mar 25, the value is 38.12. This value is within the healthy range. It has increased from 20.96 (Mar 24) to 38.12, marking an increase of 17.16.
- For Return On Assets (%), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 5. It has decreased from 1.90 (Mar 24) to 1.56, marking a decrease of 0.34.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.99 (Mar 24) to 0.00, marking a decrease of 0.99.
- For Total Debt / Equity (X), as of Mar 25, the value is 3.37. This value exceeds the healthy maximum of 1. It has increased from 3.24 (Mar 24) to 3.37, marking an increase of 0.13.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.18. It has decreased from 0.19 (Mar 24) to 0.18, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.27. This value is below the healthy minimum of 1.5. It has decreased from 1.83 (Mar 24) to 1.27, marking a decrease of 0.56.
- For Quick Ratio (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has decreased from 1.83 (Mar 24) to 1.27, marking a decrease of 0.56.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 3. It has decreased from 1.48 (Mar 24) to 1.40, marking a decrease of 0.08.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.23. This value is below the healthy minimum of 3. It has decreased from 1.27 (Mar 24) to 1.23, marking a decrease of 0.04.
- For Enterprise Value (Cr.), as of Mar 25, the value is 7,869.00. It has increased from 6,209.26 (Mar 24) to 7,869.00, marking an increase of 1,659.74.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.64. This value exceeds the healthy maximum of 3. It has decreased from 5.92 (Mar 24) to 5.64, marking a decrease of 0.28.
- For EV / EBITDA (X), as of Mar 25, the value is 8.97. This value is within the healthy range. It has decreased from 9.45 (Mar 24) to 8.97, marking a decrease of 0.48.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has decreased from 1.92 (Mar 24) to 1.08, marking a decrease of 0.84.
- For Price / BV (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1. It has decreased from 1.40 (Mar 24) to 0.73, marking a decrease of 0.67.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has decreased from 1.92 (Mar 24) to 1.08, marking a decrease of 0.84.
- For EarningsYield, as of Mar 25, the value is 0.09. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.09, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ugro Capital Ltd:
- Net Profit Margin: 10.31%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 38.12% (Industry Average ROCE: 21.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.03% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.23
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 16.4 (Industry average Stock P/E: 75.99)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 3.37
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.31%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | Equinox Business Park, Mumbai Maharashtra 400070 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Satyananda Mishra | Non Exe.Chairman&Ind.Director |
| Mr. Shachindra Nath | Vice Chairman & Mng.Director |
| Mr. Karuppasamy Singam | Independent Director |
| Ms. Tabassum Abdulla Inamdar | Independent Director |
| Mr. Karnam Sekar | Independent Director |
| Mr. Hemant Bhargava | Independent Director |
| Mr. Rajeev K Agarwal | Independent Director |
| Mr. Suresh Eshwara Prabhala | Non Exe. & Nominee Director |
| Mr. Rohit Goyal | Non Exe. & Nominee Director |
| Mr. Chetan Gupta | Non Exe. & Nominee Director |
FAQ
What is the intrinsic value of Ugro Capital Ltd?
Ugro Capital Ltd's intrinsic value (as of 08 January 2026) is ₹233.24 which is 40.51% higher the current market price of ₹166.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,550 Cr. market cap, FY2025-2026 high/low of ₹244/142, reserves of ₹2,349 Cr, and liabilities of ₹10,779 Cr.
What is the Market Cap of Ugro Capital Ltd?
The Market Cap of Ugro Capital Ltd is 2,550 Cr..
What is the current Stock Price of Ugro Capital Ltd as on 08 January 2026?
The current stock price of Ugro Capital Ltd as on 08 January 2026 is ₹166.
What is the High / Low of Ugro Capital Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ugro Capital Ltd stocks is ₹244/142.
What is the Stock P/E of Ugro Capital Ltd?
The Stock P/E of Ugro Capital Ltd is 16.4.
What is the Book Value of Ugro Capital Ltd?
The Book Value of Ugro Capital Ltd is 211.
What is the Dividend Yield of Ugro Capital Ltd?
The Dividend Yield of Ugro Capital Ltd is 0.00 %.
What is the ROCE of Ugro Capital Ltd?
The ROCE of Ugro Capital Ltd is 11.0 %.
What is the ROE of Ugro Capital Ltd?
The ROE of Ugro Capital Ltd is 8.26 %.
What is the Face Value of Ugro Capital Ltd?
The Face Value of Ugro Capital Ltd is 10.0.